Prevention Science

, Volume 15, Issue 5, pp 767–776

Cross-national Comparison of Prenatal Methamphetamine Exposure on Infant and Early Child Physical Growth: A Natural Experiment

  • Beau Abar
  • Linda L. LaGasse
  • Trecia Wouldes
  • Chris Derauf
  • Elana Newman
  • Rizwan Shah
  • Lynne M. Smith
  • Amelia M. Arria
  • Marilyn A. Huestis
  • Sheri DellaGrotta
  • Lynne M. Dansereau
  • Tara Wilcox
  • Charles R. Neal
  • Barry M. Lester
Article

Abstract

The current study seeks to compare the effects of prenatal methamphetamine exposure (PME) on infant and child physical growth between the USA and New Zealand (NZ). This cross-national comparison provides a unique opportunity to examine the potential impact of services provided to drug using mothers on child health. The longitudinal Infant Development, Environment and Lifestyle study of PME from birth to 36 months was conducted in the USA and NZ. The US cohort included 204 children with PME and 212 non-PME matched comparisons (NPME); the NZ cohort included 108 children with PME and 115 NPME matched comparisons. Latent growth curve models were used to examine effects of PME, country of origin, and the country × PME interaction on growth in length/height and weight. In regard to length/height, PME and country of origin were associated with initial length and growth over time. There was also a significant interaction effect, such that children with PME in the USA were shorter at birth than children with PME in NZ after controlling for other prenatal exposures, infant set, socioeconomic status, and maternal height. In regard to weight, there was only an effect of country of origin. Effects of PME on infant and child growth were shown to differ across countries, with exposed children in NZ faring better than exposed children in the USA. Implications for prevention programs and public policy are discussed.

Keywords

Prenatal methamphetamine exposure Length/height Weight Cross-national research 

References

  1. Abar, B., LaGasse, L. L., Derauf, C., Newman, E., Shah, R., Smith, L. M., & Lester, B. M. (2012). Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition. Psychology of Addictive Behaviors (in press).Google Scholar
  2. Acuff-Smith, K. D., Schilling, M. A., Fisher, J. E., & Vorhees, C. V. (1996). Stage-specific effects of prenatal d-methamphetamine exposure on behavioral and eye development in rats. Neurotoxicology and Teratology, 18, 199–215.CrossRefPubMedGoogle Scholar
  3. Bentler, P. M. (1990). Comparative fit indices in structural models. Psychological Bulletin, 107, 238–246.CrossRefPubMedGoogle Scholar
  4. Berman, S., O’Neill, Fears, S., Bartzokis, G., & Londen, E. D. (2008). Abuse of amphetamines and structural abnormalities in the brain. Annals of the New York Academy of Sciences, 1141, 195–220.PubMedCentralCrossRefPubMedGoogle Scholar
  5. Billing, L., Eriksson, M., Jonsson, B., Steneroth, G., & Zetterström, R. (1994). The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse & Neglect, 18, 3–9.CrossRefGoogle Scholar
  6. Block, R. I., Erwin, W. J., & Ghoneim, M. M. (2002). Chronic drug use and cognitive impairment. Pharmacological Biochemistry & Behavior Journal, 73, 491–504.CrossRefGoogle Scholar
  7. Bornstein, M. H. (2010). Handbook of cross-cultural developmental science. New York: Taylor & Francis.Google Scholar
  8. Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction, 102, 16–32.CrossRefPubMedGoogle Scholar
  9. Chang, L., Cloak, C., Jiang, C. S., Farnham, S., Tokeshi, B., Buchtal, S., et al. (2009). Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. NeuroImage, 48, 391–397.PubMedCentralCrossRefPubMedGoogle Scholar
  10. Chang, L., Smith, L., LoPresti, C., Yonekura, M., Kuo, J., Walot, I., et al. (2004). Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Research: Neuroimaging, 132, 95–106.CrossRefPubMedGoogle Scholar
  11. Chaplin, T. M., Freiburger, M. B., Mayes, L. C., & Sinha, R. (2010). Prenatal cocaine exposure, gender, and adolescent stress response: A prospective longitudinal study. Neurotoxicology and Teratology, 32, 595–604.PubMedCentralCrossRefPubMedGoogle Scholar
  12. Cloak, C. C., Ernst, T., Fujii, L., Hedemark, B., & Chang, L. (2009). Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology, 72, 2068–2075.PubMedCentralCrossRefPubMedGoogle Scholar
  13. Colliver, J. D., Kroutil, L. A., Dai, L., & Gfroerer, J. C. (2006). Misuse of prescription drugs: Data from the 2002, 2003, and 2004 surveys on drug use and health. Rockville: Substance Abuse and Mental Health Services Administration.Google Scholar
  14. Derauf, C., LaGasse, L. L., Smith, L. M., Newman, E., Shah, R., Neal, C. R., et al. (2012). Prenatal methamphetamine exposure and inhibitory control among young school-age children. Journal of Pediatrics, 161, 452–459.PubMedCentralCrossRefPubMedGoogle Scholar
  15. Duncan, T. E., Duncan, S. C., & Strycker, L. A. (2006). An introduction to latent variable growth curve modeling (2nd ed.). New York: Lawrence Erlbaum Associates.Google Scholar
  16. Eiden, R. D., Veira, Y., & Granger, D. A. (2009). Prenatal cocaine exposure and infant cortisol reactivity. Child Development, 80, 528–543.PubMedCentralCrossRefPubMedGoogle Scholar
  17. Eriksson, M., Jonsson, B., Steneroth, G., & Zetterström, R. (1994). Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatrica, 82, 612–617.Google Scholar
  18. Greenland, S., Pearl, J., & Robins, J. M. (1999). Confounding and collapsibility in causal inference. Statistical Science, 14, 29–46.CrossRefGoogle Scholar
  19. Harder, V. S., Stuart, E. A., & Anthony, J. (2010). Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychological Methods, 15, 234–249.PubMedCentralCrossRefPubMedGoogle Scholar
  20. Harkness, S. (1992). Human development in psychological anthropology. In T. Schwartz, G. M. White, & C. A. Lutz (Eds.), New directions in psychological anthropology (pp. 102–121). New York: Cambridge University Press.Google Scholar
  21. Havel, M. (1997). Annual report of the centralized substance abuse assessment project, Report to the Governor's Alliance on Substance Abuse, Des Moines, IAGoogle Scholar
  22. Hollingshead, A. (1975). Four factor index of social status. New Haven: Department of Sociology, Yale University.Google Scholar
  23. LaGasse, L. L., Derauf, C., Smith, L. M., Newman, E., Shah, R., Neal, C., et al. (2012). Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics, 129, 681–688.PubMedCentralCrossRefPubMedGoogle Scholar
  24. LaGasse, L., Seifer, R., Wright, L. L., Lester, B. M., Tronick, E. Z., Bauer, C. R., et al. (1999). The Maternal Lifestyle (MLS): The caretaking environment of infants exposed to cocaine/opiates. Pediatric Research, 45, 247a.CrossRefGoogle Scholar
  25. LaGasse, L., Wouldes, T., Newman, E., Smith, L., Shah, R., Derauf, C., et al. (2011). Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicology and Teratology, 33, 166–175.PubMedCentralCrossRefPubMedGoogle Scholar
  26. Lester, B. M., & LaGasse, L. L. (2010). Children of addicted women. Journal of Addictive Diseases, 29, 259–276.PubMedCentralCrossRefPubMedGoogle Scholar
  27. Lu, L. H., Johnson, A., O’Hare, E. D., Bookheimer, S. Y., Smith, L. M., O’Connor, M. J., et al. (2009). Effects of prenatal methamphetamine exposure on verbal member revealed with fMRI. Journal of Developmental and Behavioral Pediatrics, 30, 185–192.PubMedCentralCrossRefPubMedGoogle Scholar
  28. Mathews, B., & Kenny, M. C. (2008). Mandatory reporting legislation in the United States, Canada, and Australia: A cross-jurisdictional review of key features, differences, and issues. Child Maltreatment, 13, 50–63.CrossRefPubMedGoogle Scholar
  29. Miller, G. A., & Chapman, J. P. (2001). Misunderstanding analysis of covariance. Journal of Abnormal Psychology, 110, 40–48.CrossRefPubMedGoogle Scholar
  30. Ministry of Health. (2007). Drug use in New Zealand: Analysis of the 2003 New Zealand Health Behaviors Survey—drug use. Wellington: Ministry of Health.Google Scholar
  31. Muthén, L. K., & Muthén, B. O. (1998–2010). Mplus User’s Guide. 6th Ed. Los Angeles, CA: Muthén & Muthén.Google Scholar
  32. Nguyen, D., Smith, L. M., LaGasse, L. L., Derauf, C., Grant, P., Shah, R., et al. (2010). Intrauterine growth of infants exposed to prenatal methamphetamine: Results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Journal of Pediatrics, 157, 337–339.PubMedCentralCrossRefPubMedGoogle Scholar
  33. Nurse–Family Partnership (2012). Nurse–family partnership snapshot. Retrieved September 18, 2012 from http://www.nursefamilypartnership.org/assets/PDF/Fact-sheets/NFP_Snapshot.
  34. Olds, D. L. (2006). The nurse–family partnership: An evidence-based preventive intervention. Infant Mental Health Journal, 27, 5–25.CrossRefGoogle Scholar
  35. Plessinger, M. A. (1998). Prenatal exposure to amphetamines: Risks and adverse outcomes in pregnancy. Obstetrics and Gynecology Clinics, 25, 119–138.CrossRefPubMedGoogle Scholar
  36. Robins, J. (2001). Data, design, and background knowledge in etiologic inference. Epidemiology, 12, 313–320.CrossRefPubMedGoogle Scholar
  37. Rosenbaum, P. R. (2010). Design of observational studies. New York: Springer.CrossRefGoogle Scholar
  38. Rutter, M. (2007). Proceeding from observed correlation to causal inference: The use of natural experiments. Perspectives on Psychological Science, 2, 377–395.CrossRefPubMedGoogle Scholar
  39. Salisbury, A. L., Ponder, K. L., Padbury, J. F., & Lester, B. M. (2009). Fetal effects of psychoactive drugs. Clinical Perinatology, 36, 595–619.CrossRefGoogle Scholar
  40. Slamberova, R., Pometlova, M., & Charousova, P. (2006). Postnatal development of rat pups is altered by prenatal methamphetamine exposure. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 82–88.CrossRefGoogle Scholar
  41. Smith, L. M., Chang, L., Yonekura, M. D., Grob, C., Osborn, D., & Ernst, T. (2001). Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology, 57, 255–260.CrossRefPubMedGoogle Scholar
  42. Smith, D. K., Johnson, A. B., Pears, K. C., Fisher, P. A., & DeGarmo, D. S. (2007). Child maltreatment and foster care: Unpacking the effects of prenatal and postnatal parental substance use. Child Maltreatment, 12, 150–160.CrossRefPubMedGoogle Scholar
  43. Smith, L. M., LaGasse, L. L., Derouf, C., Grant, P., Shah, R., Arria, A., et al. (2008). Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicology and Teratology, 30, 20–28.PubMedCentralCrossRefPubMedGoogle Scholar
  44. Smith, L., Vonekura, M. L., Wallace, T. L., Berman, N., Kuo, J., & Berkowitz, C. (2003). Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. Journal of Developmental and Behavioral Pediatrics, 24, 17–23.CrossRefPubMedGoogle Scholar
  45. Sommers, I., Baskin, A., & Baskin-Sommers, A. (2006). Methamphetamine use among young adults: Health and social consequences. Addictive Behaviors, 31, 1469–1476.CrossRefPubMedGoogle Scholar
  46. Sowell, E., Leow, A., Bookheimer, S., Smith, L., O’Connor, M., Kan, E., et al. (2010). Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis. The Journal of Neuroscience, 30, 3876–3885.PubMedCentralCrossRefPubMedGoogle Scholar
  47. Substance Abuse and Mental Health Services Administration (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: SAMHSA. HHS Publication No. (SMA) 11–4658.Google Scholar
  48. Steiger, J. H. & Lind, J. (1980). Statistically-based tests for the number of common factors. Paper presented at the Annual Spring Meeting of the Psychometric Society, Iowa City, IOGoogle Scholar
  49. Terplan, M., Smith, E. J., Kozloski, M. J., & Pollack, H. A. (2009). Methamphetamine use among pregnant women. Obstetrics and Gynecology, 113, 1285–1291.CrossRefPubMedGoogle Scholar
  50. Wijetunga, M., Seto, R., Lindsay, J., & Schatz, I. (2003). Crystal methamphetamine-associated cardiomyopathy: Tip of the iceberg? Journal of Toxicology. Clinical Toxicology, 41, 981–986.CrossRefPubMedGoogle Scholar
  51. Wilkins, C., & Sweetsur, P. (2008). Trends in population drug use in New Zealand: Findings form national household surveying of drug use in 1998, 2001, 2003, and 2006. The New Zealand Medical Journal, 121, 61–71.PubMedGoogle Scholar
  52. Williams, M. T., Moran, M. S., & Vorhees, C. V. (2004). Behavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats. International Journal of Developmental Neuroscience, 22, 273–283.PubMedCentralCrossRefPubMedGoogle Scholar
  53. Wouldes, T., LaGasse, L., Sheridan, J., & Lester, B. (2004). Maternal methamphetamine use during pregnancy and child outcome: What do we know? Journal of the New Zealand Medical Association, 117, U1180.Google Scholar
  54. Wu, M., LaGasse, L.L., Wouldes, T.A., Arria, A.M., Wilcox, T., Derauf, C., … Lester, B.M. (2012). Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States. Maternal and Child Health Journal, epub ahead of print.Google Scholar
  55. Zabaneh, R., Smith, L., LaGasse, L., Derauf, C., Newman, E., Shah, R., et al. (2012). The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years. American Journal of Perinatology, 29, 203–210.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Society for Prevention Research 2013

Authors and Affiliations

  • Beau Abar
    • 1
  • Linda L. LaGasse
    • 1
  • Trecia Wouldes
    • 2
  • Chris Derauf
    • 3
  • Elana Newman
    • 4
  • Rizwan Shah
    • 5
  • Lynne M. Smith
    • 6
  • Amelia M. Arria
    • 7
  • Marilyn A. Huestis
    • 8
  • Sheri DellaGrotta
    • 1
  • Lynne M. Dansereau
    • 1
  • Tara Wilcox
    • 1
  • Charles R. Neal
    • 3
  • Barry M. Lester
    • 1
  1. 1.Brown Center for the Study of Children at RiskAlpert Medical School, Women and Infants Hospital of RIProvidenceUSA
  2. 2.Department of Psychological MedicineThe University of AucklandAucklandNew Zealand
  3. 3.John A. Burns School of Medicine, Department of PediatricsUniversity of HawaiiPearl CityUSA
  4. 4.Department of PsychologyThe University of TulsaTulsaUSA
  5. 5.Blank Hospital Regional Child Protection CenterIowa HealthDes MoinesUSA
  6. 6.Department of PediatricsLABioMed Institute at Harbor-UCLA Medical CenterLos AngelesUSA
  7. 7.Family Science Department–Center on Young Adult Health and DevelopmentUniversity of Maryland School of Public HealthCollege ParkUSA
  8. 8.Intramural Research ProgramNational Institute on Drug AbuseBethesdaUSA

Personalised recommendations